Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Expert Opinion on Therapeutic Targets|January 19, 2013
Endoglin for tumor imaging and targeted cancer therapyMadelon Paauwe, Peter ten Dijke, Lukas J A C Hawinkels
International Journal of Molecular Sciences|December 30, 2020
Endoglin Targeting: Lessons Learned and Questions That RemainYingmiao Liu, Madelon Paauwe, Andrew B Nixon, et al.
Blood|March 14, 2014
Antiapoptotic potency of Bcl-2 proteins primarily relies on their stability, not binding selectivityRogier W Rooswinkel, Bert van de Kooij, Evert de Vries, et al.
Oncotargets and Therapy|November 8, 2021
Targeting Endoglin Expressing Cells in the Tumor Microenvironment Does Not Inhibit Tumor Growth in a Pancreatic Cancer Mouse ModelMark J A Schoonderwoerd, Sarah K Hakuno, Martijn Sassen, et al.
Cancer Research|November 21, 2019
Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic StressIrem Kaymak, Carina R Maier, Werner Schmitz, et al.
Elife|May 26, 2021
Phenotypic plasticity underlies local invasion and distant metastasis in colon cancerAndrea Sacchetti, Miriam Teeuwssen, Mathijs Verhagen, et al.
Oncogene|January 25, 2020
Bidirectional tumor/stroma crosstalk promotes metastasis in mesenchymal colorectal cancerSarah Ouahoud, Philip W Voorneveld, Lennart R A van der Burg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2015
Activin Receptor-like Kinase 1 Ligand Trap Reduces Microvascular Density and Improves Chemotherapy Efficiency to Various Solid TumorsLukas J A C Hawinkels, Amaya Garcia de Vinuesa, Madelon Paauwe, et al.
Leukemia & Lymphoma|June 18, 2025
Combinability of epcoritamab CD20-targeting T-cell engager and CD20 antibody-targeted therapies in B-cell non-Hodgkin lymphomaDurga B Dandamudi, Iwona M Konieczna, Kelly M Calabrese, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2020
Targeting Endoglin-Expressing Regulatory T Cells in the Tumor Microenvironment Enhances the Effect of PD1 Checkpoint Inhibitor ImmunotherapyMark J A Schoonderwoerd, Maaike F M Koops, Ricardo A Angela, et al.
Pageof 2